New Risk Score Tool More Accurately Predicts Patie...
Aggressive measures to treat diabetics make many o...
NYT Story on Type 2 Diabetes CVD risk reduction fa...
No increased atherosclerotic-plaque burden in cops...
Nanoparticle detonations may be able to burn vascu...
ACCORD: Fenofibrate no benefit to statin therapy i...
Caution urged in reducing blood pressure in patien...
EXCEL trial will determine safety and efficacy of ...